Ludmila V. Stepanova

Ludmila V. Stepanova

Auto-generated profile, based on publicly available information

Ludmila V. Stepanova

Voyno-Yasenetsky Krasnoyarsk State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2020 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
NIN.A. Ilenkova
N.A. Ilenkova
LSL.V. Stepanova
L.V. Stepanova
OKO.S. Konopleva
O.S. Konopleva
MFM.V. Fedorov
M.V. Fedorov
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.

1 January 2023 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
EKElena Kondatyeva
Elena Kondatyeva
ELE.V. Loshkova
E.V. Loshkova
NIN.A. Ilenkova
N.A. Ilenkova
YMYu.L. Mizernitskiy
Yu.L. Mizernitskiy
LKL.Ya. Klimov
L.Ya. Klimov
NON.D. Odinaeva
N.D. Odinaeva

19 October 2024 in Astrakhan Medical Journal
Verified
Journal Article
Open access
PDF file
NIN. A. Il’yEnkova
N. A. Il’yEnkova
DSD. F. Sergienko
D. F. Sergienko
LSL. V. Stepanova
L. V. Stepanova
SPS. Y. Pastukhova
S. Y. Pastukhova
SDS. S. Dvoryanskaya
S. S. Dvoryanskaya
The main principle of the treatment of bronchial asthma is rational basic therapy, with priority appointment of inhaled glucocorticosteroids. The basis of the effectiveness of treatment is determined by the correct choice of the form of drug delivery, training the patient in inhalation skills and constant monitoring of the correct use of the inhaler. The article demonstrates the clinical observation of the formation of asthmatic status in a child with mild bronchial asthma. The deterioration of the condition and severe exacerbation was caused by insufficient intake of basic therapy funds into the respiratory tract due to improper inhalation techniques due to the patient's lack of skills in using an inhaler. At the same time, the patient was not trained and the necessary control over the correctness of the inhalation technique was not carried out at the outpatient stage.

17 November 2025 in Consilium Medicum
Verified
Journal Article
Open access
PDF file
NINatalya A. Ilyenkova
Natalya A. Ilyenkova
DSDiana F. Sergienko
Diana F. Sergienko
LSLudmila V. Stepanova
Ludmila V. Stepanova
SPSvetlana Yu. Pastukhova
Svetlana Yu. Pastukhova
LDLilya M. Dobronovich
Lilya M. Dobronovich
ИАИльенкова Наталья Анатольевна
Ильенкова Наталья Анатольевна
The article describes a clinical case of asthmatic status in a child with severe bronchial asthma, which clearly demonstrates the importance of organizing rational medical care for this group of patients at the stage of a territorial polyclinic, where timely measures should be taken to assess the effectiveness of current anti-inflammatory therapy, review its scope, and especially paperwork to provide patients with vital medicines in the preferential drug treatment system provision of citizens. Personalized phenotype determination and therapy selection are needed for patients who do not achieve control on medium and high doses of inhaled glucocorticosteroids in combination with long-acting β2-agonists and who have a history of severe exacerbations. It is important to observe the continuity of medical care for such patients at the inpatient and outpatient stages.

9 June 2022 in Лечащий врач
Verified
Journal Article
Closed access
NIN.A. Ilenkova
N.A. Ilenkova
LSL.V. Stepanova
L.V. Stepanova
DSD.F. Sergienko
D.F. Sergienko
Understanding the atopic march hypothesis is important for the clinical manifestation of allergic diseases, since it determines the prognosis of whether people with early symptoms of atopy will follow the traditional atopic march. Currently, there is substantial evidence of the presence of the atopic march, but its prevalence may be exaggerated. The legitimacy of the atopic march as a model for the formation of atopic diseases is currently being discussed. Atopic dermatitis reaches its peak in early childhood, opening the door for the subsequent development of the atopic march. It is practically significant to establish risk factors that determine the start of the atopic march: early onset of atopic dermatitis, severity, persistence of the disease, presence of FLG mutation, polysensitization, atopy on the part of parents. The analysis of prospective studies of patients with atopic march from infancy to adulthood is valuable, which will allow us to develop specific programs for the timely prevention of the implementation of severe allergic diseases. The article presents a case from pediatric practice with early symptoms of atopy and the implementation of the atopic march in a 15-year-old patient. The clinical case demonstrates early symptoms and consistent development of atopic diseases: food allergy, atopic dermatitis, bronchial asthma, allergic rhinitis with the addition of allergic conjunctivitis, progressive severity of diseases, against the background of polyvalent sensitization and hereditary burden of allergic diseases. Thus, the clinical example of a 15-year-old patient demonstrates that the atopic march is a reality. On the example of a clinical case, several important factors were identified that increase the risk of developing other allergic diseases: earlier, the onset of symptoms of atopy – food allergy, then the consistent development of diseases of atopic dermatitis, bronchial asthma, allergic rhinitis, against the background of emerging polyvalent sensitization to allergens and hereditary burden of allergic diseases. This example showed that the atopic march can be realized due to sensitization through an early broken barrier of atopic dermatitis, due to common possibly genetic and environmental factors.

1 January 2025 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
ILI.A. Lizinfeld
I.A. Lizinfeld
MEMoscow Russian Medical Academy Of Continuous Professional Education
Moscow Russian Medical Academy Of Continuous Professional Education
NPNatalia Pshenichnaya
Natalia Pshenichnaya
LSL.V. Stepanova
L.V. Stepanova
Acute respiratory diseases often require antibiotics, which increases the risk of antibiotic-associated diarrhea and lowers immunity in kids. Using probiotics helps prevent these complications and improves clinical outcomes. Objective. To evaluate the effectiveness of the complex probiotic Acipol Forte in children aged 5–8 years receiving antibiotic therapy for acute respiratory infections of bacterial etiology. Patients and methods. The study included 102 children aged 5 to 8 years with acute respiratory diseases. The main group, Acipol Forte (51 children), received the probiotic Acipol Forte together with antibiotics, while the control group (51 children) received only antibiotics. The incidence of antibiotic-associated diarrhea, the incidence of recurrence of acute respiratory infections, and the duration of symptoms were assessed during 50 days of observation. Results. The incidence of antibiotic-associated diarrhea was 1.9% in the Acipol Forte group and 60.7% in the control group (p < 0.05). Recurrences of acute respiratory diseases were observed in 7.8% of children in the main group and in 54.9% of children in the control group (p < 0.05). The symptoms of the disease in children receiving the probiotic were significantly less prolonged. No adverse events were identified with the use of the probiotic. The probiotic Acipol Forte, containing live cultures of lactobacilli, bifidobacteria, and zinc citrate, significantly reduces the risk of developing antibiotic-associated diarrhea and recurrence of acute respiratory infections. This is due to the improvement of the intestinal microflora and stimulation of the immune system. Conclusion. The use of the probiotic Acipol Forte is safe and effective for the prevention of antibiotic-associated diarrhea and recurrent acute respiratory diseases in children receiving antibacterial therapy, which helps to reduce the severity and duration of the disease. Key words: antibacterial therapy, antibiotic-associated diarrhea, Acipol Forte, children, immunity, acute respiratory infections, probiotics, prevention